$37.64
2.90% yesterday
Nasdaq, Oct 14, 10:00 pm CET

Phibro Animal Health Corporation Class A Target price 2025 - Analyst rating & recommendation

Phibro Animal Health Corporation Class A Classifications & Recommendation:

Buy
11%
Hold
44%
Sell
44%

Phibro Animal Health Corporation Class A Price Target

Target Price $34.68
Price $37.64
Deviation
Number of Estimates 6
6 Analysts have issued a price target Phibro Animal Health Corporation Class A 2026 . The average Phibro Animal Health Corporation Class A target price is $34.68. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 1 Analysts recommend Phibro Animal Health Corporation Class A to buy, 4 to hold and 4 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Phibro Animal Health Corporation Class A stock has an average upside potential 2026 of . Most analysts recommend the Phibro Animal Health Corporation Class A stock at Sell or hold.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '25 2026
Estimates
Revenue Billion $ 1.30 1.49
27.37% 14.80%
EBITDA Margin 14.12% 15.43%
29.70% 9.31%
Net Margin 3.72% 7.31%
1,465.69% 96.34%

6 Analysts have issued a sales forecast Phibro Animal Health Corporation Class A 2026 . The average Phibro Animal Health Corporation Class A sales estimate is

$1.5b
Unlock
. This is
14.80% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.5b 18.88%
Unlock
, the lowest is
$1.4b 9.94%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $1.3b 27.37%
2026
$1.5b 14.80%
Unlock
2027
$1.5b 3.16%
Unlock
2028
$1.6b 2.74%
Unlock

6 Analysts have issued an Phibro Animal Health Corporation Class A EBITDA forecast 2026. The average Phibro Animal Health Corporation Class A EBITDA estimate is

$230m
Unlock
. This is
25.45% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$239m 30.55%
Unlock
, the lowest is
$218m 18.90%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $183m 65.20%
2026
$230m 25.45%
Unlock
2027
$244m 6.40%
Unlock
2028
$258m 5.83%
Unlock

EBITDA Margin

2025 14.12% 29.70%
2026
15.43% 9.31%
Unlock
2027
15.91% 3.11%
Unlock
2028
16.39% 3.02%
Unlock

6 Phibro Animal Health Corporation Class A Analysts have issued a net profit forecast 2026. The average Phibro Animal Health Corporation Class A net profit estimate is

$109m
Unlock
. This is
125.51% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$113m 134.56%
Unlock
, the lowest is
$103m 113.99%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $48.3m 1,894.21%
2026
$109m 125.51%
Unlock
2027
$120m 10.63%
Unlock
2028
$134m 11.59%
Unlock

Net Margin

2025 3.72% 1,465.69%
2026
7.31% 96.34%
Unlock
2027
7.84% 7.25%
Unlock
2028
8.52% 8.67%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jun '25 2026
Estimates
Earnings Per Share $ 1.19 2.69
1,883.33% 126.05%
P/E 13.62
EV/Sales 1.43

6 Analysts have issued a Phibro Animal Health Corporation Class A forecast for earnings per share. The average Phibro Animal Health Corporation Class A EPS is

$2.69
Unlock
. This is
126.05% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$2.79 134.45%
Unlock
, the lowest is
$2.55 114.29%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $1.19 1,883.33%
2026
$2.69 126.05%
Unlock
2027
$2.97 10.41%
Unlock
2028
$3.32 11.78%
Unlock

P/E ratio

Current 30.74 43.73%
2026
13.62 55.69%
Unlock
2027
12.31 9.62%
Unlock
2028
11.03 10.40%
Unlock

Based on analysts' sales estimates for 2026, the Phibro Animal Health Corporation Class A stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.64 28.13%
2026
1.43 12.95%
Unlock
2027
1.38 3.06%
Unlock
2028
1.35 2.67%
Unlock

P/S ratio

Current 1.14 25.86%
2026
1.00 12.89%
Unlock
2027
0.97 3.07%
Unlock
2028
0.94 2.66%
Unlock

Current Phibro Animal Health Corporation Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
B of A Securities
Locked
Locked
Locked Aug 29 2025
JP Morgan
Locked
Locked
Locked Jul 07 2025
Morgan Stanley
Locked
Locked
Locked Jun 25 2025
Morgan Stanley
Locked
Locked
Locked May 08 2025
Barclays
Locked
Locked
Locked Feb 10 2025
Morgan Stanley
Locked
Locked
Locked Dec 17 2024
Barclays
Locked
Locked
Locked Nov 12 2024
Analyst Rating Date
Locked
B of A Securities:
Locked
Locked
Aug 29 2025
Locked
JP Morgan:
Locked
Locked
Jul 07 2025
Locked
Morgan Stanley:
Locked
Locked
Jun 25 2025
Locked
Morgan Stanley:
Locked
Locked
May 08 2025
Locked
Barclays:
Locked
Locked
Feb 10 2025
Locked
Morgan Stanley:
Locked
Locked
Dec 17 2024
Locked
Barclays:
Locked
Locked
Nov 12 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today